Targeting the ADPKD methylome using nanoparticle-mediated combination therapy
Open Access
- 1 June 2023
- journal article
- research article
- Published by AIP Publishing in APL Bioengineering
- Vol. 7 (2) , 026111
Abstract
DNA methylation aberrancies are found in autosomal dominant polycystic kidney disease (ADPKD), which suggests the methylome to be a promising therapeutic target. However, the impact of combining DNA methylation inhibitors (DNMTi) and ADPKD drugs in treating ADPKD and on disease-associated methylation patterns has not been fully explored. To test this, ADPKD drugs, metformin and tolvaptan (MT), were delivered in combination with DNMTi 5-aza-2′-deoxycytidine (Aza) to 2D or 3D cystic Pkd1 heterozygous renal epithelial cells (PKD1-Het cells) as free drugs or within nanoparticles to enable direct delivery for future in vivo applications. We found Aza synergizes with MT to reduce cell viability and cystic growth. Reduced representation bisulfite sequencing (RRBS) was performed across four groups: PBS, Free-Aza (Aza), Free-Aza+MT (F-MTAza), and Nanoparticle-Aza+MT (NP-MTAza). Global methylation patterns showed that while Aza alone induces a unimodal intermediate methylation landscape, Aza+MT recovers the bimodality reminiscent of somatic methylomes. Importantly, site-specific methylation changes associated with F-MTAza and NP-MTAza were largely conserved including hypomethylation at ADPKD-associated genes. Notably, we report hypomethylation of cancer-associated genes implicated in ADPKD pathogenesis as well as new target genes that may provide additional therapeutic effects. Overall, this study motivates future work to further elucidate the regulatory mechanisms of observed drug synergy and apply these combination therapies in vivo.Keywords
Funding Information
- National Science Foundation (DMS1763272)
- Simons Foundation (594598)
- National Institutes of Health (DP2CA250382-01)
- California Institute for Regenerative Medicine (EDUC4-12822)
- Alfred E. Mann Institute for Biomedical Engineering, University of Southern California (AMI Fellowship)
- National Institutes of Health (DP2-DK121328)
- Division of Materials Research (BMAT 2132744)
- Women in Science and Engineering, University of Southern California (WiSE Major Support Award)
- National Cancer Institute (P30CA-062203)
This publication has 70 references indexed in Scilit:
- Age-associated epigenetic drift: implications, and a case of epigenetic thrift?Human Molecular Genetics, 2013
- Integrative Genomics Viewer (IGV): high-performance genomics data visualization and explorationBriefings in Bioinformatics, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- ChromHMM: automating chromatin-state discovery and characterizationNature Methods, 2012
- Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applicationsBioinformatics, 2011
- Activating AMP-activated protein kinase (AMPK) slows renal cystogenesisProceedings of the National Academy of Sciences, 2011
- Quantitative comparison of genome-wide DNA methylation mapping technologiesNature Biotechnology, 2010
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell IdentitiesMolecular Cell, 2010
- BEDTools: a flexible suite of utilities for comparing genomic featuresBioinformatics, 2010
- Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolutionNature Methods, 2010